TY - CHAP M1 - Book, Section TI - Reactive Erythemas A1 - Shinkai, Kanade A1 - Fox, Lindy P. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. PY - 2021 T2 - Current Medical Diagnosis & Treatment 2021 AB - Key Clinical Updates in Reactive ErythemasLigelizumab is effective for chronic urticaria in early clinical trials.Etanercept is emerging as a promising therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis and is now the treatment of choice in some centers. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2023/02/04 UR - accessmedicine.mhmedical.com/content.aspx?aid=1175804635 ER -